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The M1 and M2 states of macrophage polarization are the two extremes of a physio-
logic/phenotypic continuum that is dynamically influenced by environmental signals. The
M1/M2 paradigm is an excellent framework to understand and appreciate some of the
diverse functions that macrophages perform. Molecular analysis of mouse and human
macrophages indicated that they gain M1 and M2-related functions after encountering
specific ligands in the tissue environment. In this perspective, I discuss the function of
recepteur d’origine nantais (RON) receptor tyrosine kinase in regulating the M2-like state
of macrophage activation Besides decreasing pro-inflammatory cytokine production in
response to toll-like receptor-4 activation, macrophage-stimulating protein strongly sup-
presses nitric oxide synthase and at the same time upregulates arginase, which is the rate
limiting enzyme in the ornithine biosynthesis pathway. Interestingly, RON signaling pre-
served some of the characteristics of the M1 state, while still promoting the hallmarks of
M2 polarization. Therefore, therapeutic modulation of RON activity can shift the activation
state of macrophages between acute and chronic inflammatory states.
Keywords: macrophages, polarization, RON signaling, tumor promotion, immune therapy
INTRODUCTION
Macrophages perform the essential function of preserving tissue
homeostasis following infection or tissue damage in all animals in
the absence of B and T cells. Macrophages originate from bone
marrow-derived monocytic cells through a process of differenti-
ation, directed by the activation of specific transcription factors
(1–3). Circulating monocytes are recruited to tissues, where they
differentiate into functionally distinct subsets of cells with distinct
phenotypic characteristics. In response to the tissue microenviron-
ment, these cells can either produce pro-inflammatory cytokines to
kill the offending foreign pathogen and polarize T-cells to mount
an adaptive immune response, or participate in tissue repair by
increasing their phagocytic activity and producing growth factors
for tissue healing and regeneration. The cellular plasticity is a hall
mark of macrophages and the complex signaling pathways that
contribute to these biochemical and functional differentiation is
beginning to be understood (4, 5).
The two states of macrophage activation, “Classical” (M1) and
“Alternative” (M2) occupy two extremes of a phenotypic contin-
uum in which macrophages respond to secreted factors to evoke
distinct functional responses (6, 7). These functional responses
are regulated by a combination of signaling pathway modulators
and transcription factors. As an example, combination of IFN-γ
with toll-like receptor (TLR) pathway activation produces a com-
plete M1 phenotype in macrophages mediated by the activation of
STAT1 and NF-κB transcription factors. By contrast, IFN-γ alone
causes a partial M1 response mediated by STAT1 transcription fac-
tor at sites of infection. Similarly, macrophage M2 phenotype and
response are fine-tuned at tissue-specific sites by the activation of
distinct sets of chemicals, such as IL-10 in the gut, or IL-4 and fatty
acids in the adipose tissues (8, 9).
The activation of macrophages (AAM) into M1- or M2-type is
dictated by the cytokine milieu of the tissue microenvironment.
Monocytes are primed to differentiate in response to macrophage
colony stimulating factor (M-CSF) or by granulocyte macrophage
colony stimulating factor (GM-CSF) (2, 3). Further priming is dic-
tated by a balance between IFN-γ and IL-4, the former pushing the
macrophages into an M1 state and the latter into an M2 state. The
primed macrophages receive additional signals in the form of TLR
stimulation to display the full complement of classical and alter-
native activation functions. Whereas, M1-primed macrophages
produce pro-inflammatory cytokines and inducible nitric oxide
synthase (iNOS) upon TLR activation, M2-primed macrophages
produce arginase, IL-10, and growth factors such as transform-
ing growth factor-β (TGF-β), vascular endothelial growth fac-
tor (VEGF), and epidermal growth factor (EGF) among others.
Interestingly, these macrophage phenotypes can be reversed and
brought back to the state of naïve macrophages by growing them in
the absence of any priming factors for a couple of days, indicating
reversibility of the response (10, 11).
INVOKING THE M1 PHENOTYPE OF MACROPHAGES
M1 polarization can be evoked by treating naïve macrophages
with a combination of IFN-γ and LPS. Macrophages express a
variety of microbial pattern recognition receptors (PRRs), such as
TLRs that recognize pathogen – or danger associated molecular
patterns to clear the offending signal (12, 13). A large number of
inflammatory cytokines including TNF-α, IFN-γ IL-12p40, IL-6
are produced rapidly after TLR-4 activation. The delayed TLR-4
response is triggered by the recruitment of TIR-containing adap-
tor protein (TRIF) and TRIF-related adaptor molecule (TRAM) to
induce IFN-β and trigger the interferon response (14). Together,
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the NF-κB, p38 MAPK, and IFN-β pathways regulate the out-
put of the TLR-4 signaling. A key enzyme of arginine metab-
olism, iNOS metabolizes arginine to make nitric oxide (NO),
a potent anti-microbial agent. Production of NO is a hallmark
of M1 macrophages and IFN-γ regulates NO production via
transcriptional upregulation of iNOS (4, 15).
Built within these signaling circuits are negative feedback loops
that circumscribe the intensity and duration of the LPS response.
Proteins, such as dual specificity phosphatases (DUSP) and sup-
pressor of cytokine signaling (SOCS) are induced to dephos-
phorylate upstream activators of the MAPK pathway and inhibit
signaling downstream of the interferon receptor, respectively (6,
16). As part of body’s defense mechanism, M1 polarization is crit-
ical to mount an effective innate immune response against the
offending pathogen. However, the body can sustain extensive tissue
damage if the pro-inflammatory responses are allowed to persist.
Therefore, these multiple feedback loops are turned on down-
stream of TLR-4 and cytokine-signaling pathways that quickly
reduce the output from these pro-inflammatory signaling circuits
(17, 18).
INVOKING THE M2 PHENOTYPE OF MACROPHAGES
Tissue resident macrophages assume an M2 phenotype by default.
This phenotype, also defined as alternative AAM or M2-type of
macrophages can be induced by IL-4+ IL-13 and by other sig-
naling molecules (6, 9). In this state, macrophages metabolize
arginine into ornithine by the expression of arginase-1 that diverts
arginine from the production of NO and citrulline. (15). The M2
macrophages also produce growth factors and extracellular matrix
remodeling enzymes that promote processes related to tissue repair
and healing. Additionally, their phagocytic activity is increased to
help in clearing tissue debris. The M2 activity is sustained by fac-
tors produced by injured tissues such as TGF-β and adenosine
(4, 19).
SIGNALING PATHWAYS MEDIATING MACROPHAGE
POLARIZATION
The signaling circuitry leading to changes in gene expression
pattern during macrophage polarization is complex (16). Dif-
ferent subsets of tissue-specific macrophages are dependent on
different signaling pathways to polarize and sustain their polar-
ized state. As an example, c-jun N-terminal kinase pathway
(JNK) is required for the adipose tissue-associated macrophages
to assume M1-phenotype (20). Polarization of macrophages by
the phosphatidyl inositol-3 kinase (PI3K) pathway is mediated
by the activation of AKT1 and AKT2 kinases. Genetic abla-
tion experiments revealed that AKT1 and 2 regulate macrophage
M1 and M2 phenotype in a reciprocal pattern (21, 22). In
the absence of AKT1, macrophages produce pro-inflammatory
cytokines resembling the M1 phenotype, whereas in the absence
of AKT2 the cells express markers of M2 polarization such
as Arg-1, Fizz-1, and IL-10 (21, 23, 24). Interestingly, prelimi-
nary data support that this reciprocal regulation of macrophage
M1/M2 phenotypes is mediated by a micro-RNA, mir-155,
and its target transcriptional regulator CAAT-enhanced bind-
ing protein-β play an important role (23). JAK/STAT pathway
downstream to IFN-γ is a strong inducer of M1 polarization,
although to reach the full spectrum of the M1-phenotypic state,
dual activation of the TLR-4 and IFN-γ pathways are required
(25, 26).
Signals that promote M2 polarization are diverse and a vari-
ety of molecules from cytokines to growth factors can influence
this transition (6). The IL-4/IL-13 combination is a physiological
mediator of the M2 state that impinges on the transcription factor
STAT-6 to induce cell surface expression of M2 markers and meta-
bolic reprograming (9). In the absence of IL-4/IL-13, M-CSF and
IL-10 can push macrophages to assume an M2 phenotype medi-
ated by the transcription factor STAT-3 and SP-1, respectively.
In this state, the macrophages become highly phagocytic, produce
growth factors that promote repair of wound or tissue damage, and
promote Th-2 immune response. Fcγ receptors in combination
with LPS promotes Th-2 response, upregulates antigen presenta-
tion, turns off IL-12, and induces IL-10 production by activating
the Syk and PI3K pathways that cross-talk with TLR signaling.
Finally, glucocorticoids promote macrophage adherence, spread-
ing, phagocytosis, induction of complement proteins, and secre-
tion of IL-10 by directly engaging the macrophage transcription
machinery.
Integrating the function of M1 and M2 macrophages in a
physiological setting raises several questions:
1. Are the M1 and M2 macrophage states mutually exclusive in a
tissue environment?
2. Can a cell transition from one state to the other directly, or are
there other intermediate states?
3. Can a macrophage assume characteristics of both M1 and
M2 states? How do they arise? Do they represent a fleeting
intermediate, or can cells in this state be stabilized?
Answers to these questions are not fully known. However, M1-
and M2-polarized macrophages are found as mixed populations
in the tissue microenvironment. Depending on the inflamma-
tory stimuli, one state may dominate over the other. Both M1
and M2 states are functionally and phenotypically heterogeneous.
The translatability of macrophage M1/M2 polarization in nor-
mal homeostasis and in diseases have remained elusive beyond
the fact that M1 macrophages favor bacterial and viral elimina-
tion, whereas M2 macrophages give protection against helminthes
and other parasites and participate in tissue repair. Observations
in vitro cannot always be readily applied to in vivo situations and
many of the macrophage responses discussed above are yet to find
validation in vivo (27).
HOW FUNCTIONAL STATES OF MACROPHAGES ARE
MODULATED BY GROWTH FACTOR SIGNALING
So far in our discussion, the macrophage phenotypic and func-
tional states have been described in the context of inflammation
or interaction between pathogens and immune cells. However,
M2-polarized macrophages also perform essential functions in
the resolution of tissue inflammation, remodeling of the tissue
microenvironment during wound healing and repair of tissue
damage. In the next section, the effect of growth factor signal-
ing on macrophage polarization, and its implication in human
cancer is discussed.
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FIGURE 1 | Recepteur d’origine nantais (RON) promotes macrophage
M2 polarization. (A) Structure of RON and MSP proteins. (B) RON
signaling alters macrophage phenotype and restores the balance between
M1- and M2-polarized states.
Among the growth factor receptors known to modulate
macrophage behavior and function is the receptor tyrosine kinase
“recepteur d’origine nantais” (RON) (28, 29). The ligand for RON,
macrophage-stimulating protein (MSP) regulates macrophage
motility and its phagocytic activity (28). MSP is produced by
the liver and circulates in an inactive form in the serum. MSP
activation occurs as a result of proteolytic processing of Pro-
MSP resulting in active MSP. Several trypsin like proteases such
as matriptase, hepsin, and hepatocyte growth factor-A (HGF-A)
cleave inactive pro-MSP into an active form (30) (Figure 1A).
These proteases are known to be activated at sites of inflammation
and can be a source of active MSP that can turn on RON signaling
on macrophages and epithelial cells at these sites.
Genetic ablation of RON kinase activity in mice leads to viable
and fertile progenies with no apparent developmental defects.
However, studies showing that RON knockout (RON-KO) mice
are sensitive to LPS challenge suggested that RON signaling neg-
atively regulates downstream effects of TLR-4 activation (31, 32).
Further studies by many groups have led to a general model in
which RON signaling promotes some of the functional and phe-
notypic traits of M2-like macrophages, in particular, a strong
suppression of pro-inflammatory cytokine production in response
to LPS (33, 34) or LPS+ IFN-γ (35), suppression of iNOS (36),
induction of arginase-1 (37, 38), and expression of scavenger
receptors (34). Interestingly, treatment of peritoneal macrophages
with MSP alone induced activation of MAPK and PI3K pathways,
but failed to induce any of the hall marks of M2 polarization such
as expression of arginase-1, scavenger receptors, or IL-10 (34).
When MSP was combined with LPS stimulation, macrophages
exhibited hallmarks of M2-polarized state (Figure 1B). Further,
global gene expression analysis and measurement of cytokines in
the conditioned media indicated that RON signaling had minimal
effect on TLR-4-mediated early NF-κB activation – the effect being
significantly pronounced at later time points (34).
Taken together, these observations support that RON signal-
ing has dual effect on macrophages. On the one hand, it enhances
macrophage motility and survival without any input from TLR sig-
naling, but on the other hand, it significantly modifies the TLR-4
signaling output when LPS is present along with MSP. Interest-
ingly, the reprograming of the TLR-4 signaling circuits by RON is
sensitive to mice genetic background (34).
IMPACT OF GENETIC BACKGROUND AND DIFFERENTIAL
EFFECT OF RON ON MACROPHAGE POLARIZATION
Studies employing different mice strains have revealed that host
genetic background significantly influences the metabolic repro-
graming and behavior of macrophages when exposed to LPS or
IFN-γ (39). Mills et al. first reported that whereas macrophages
from C57Bl/6 mice produced citrulline and nitric oxide (NO) in
response to LPS or IFN-γ, those from BALB/c background pro-
duced ornithine (40). Both NO and ornithine are the products
of differential arginine metabolism mediated by the expression
of enzymes iNOS and arginase-1, respectively, and this “fork in
the arginine metabolism” is recognized as one of the hallmarks of
M1 and M2 polarization (4, 39). Gene expression profiles com-
paring bone marrow-derived macrophages from different mice
strains further revealed that in response to LPS, timing and inten-
sity of expression of genes differed significantly between mice
strains (41).
Interestingly, RON signaling modulated the TLR-4 responses
of macrophages between C57Bl/6 (M1-polarized) and FVB (M2-
polarized) mice differently (34). Whereas MSP strongly sup-
pressed LPS-induced production of pro-inflammatory cytokines
in macrophages from FVB background, the effect was minimal
in the C57Bl/6 background. A clue to the mechanism came from
analyzing the effect of RON signaling on LPS-induced gene expres-
sion in macrophages. LPS induced the transcriptional targets of
the NF-κB and MAPK pathways early on, and RON signaling had
no effect on most of the early response genes. The late response
genes, dominated by the transcriptional targets of interferon sig-
naling, selected NF-κB target genes, and genes associated with
tissue repair and immune tolerance was modulated variably by
RON. RON suppressed most of the targets of the interferon path-
way (50% of the downregulated genes at the later time point were
targets of interferon signaling), as well as few selected targets of the
NF-κB pathway (TNF-α), but enhanced the expression of tissue
repair (EGF, PDGF, MMP9) and immune tolerance genes (IL-10,
IL-19, CTLA-2A). The kinetics of IFN-β expression in response to
TLR-4 activation was rapid (1 h) in macrophages from FVB mice,
whereas it was significantly delayed (8 h) in C57Bl/6 background.
This early upregulation of IFN-β in FVB mice was blunted by
RON signaling resulting in a strong inhibition of the expression of
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FIGURE 2 | Overview of the impact of the RON pathway on M1 versus
M2 differentiation program in the context ofTLR-4 signaling. Transcript
and protein levels of IFN-β and TNF-α were compiled from experimental
values. Protein or mRNA levels at each time point are expressed as
percentage of maximal expression (100%). We propose that RON signaling
in macrophages from FVB mice preserves M2 differentiation in the
presence of TLR-4 signaling, whereas C57Bl6 macrophages maintain
polarization toward M1 cells in the presence of RON signaling. Taken from
Chaudhuri et al. (34).
interferon regulatory factors (IRFs) and target genes of the inter-
feron pathway at later time points. The IFN-β expression however,
was minimally affected by RON signaling in C57Bl/6 macrophages
partly because of the delayed expression of IFN-β in this strain
background, and partly as a result of high expression of TNF-α, IL-
12, and IL-6, which by themselves can modulate the expression of
IFN-β independently of LPS (34). The final outcome of the inter-
play between RON and LPS signaling in these two mice strains
resulted in the stabilization of M2-polarized state in FVB mice
even in the presence of a strong M1-polarizing signal, but failed
to alter the phenotype of macrophages from C57Bl/6 background
(Figure 2).
In addition to affecting the polarized behavior of macrophages,
RON kinase-deficient FVB mice formed less number of tumors,
which developed with a delayed kinetics in two models of chemi-
cal induced carcinogenesis (34, 42). This inhibitory effect was lost
in the C57Bl/6 RON-KO background (34). Additionally, deple-
tion of CD8+ T-cells in a transplantable fibrosarcoma model in
FVB mice suppressed the rejection of tumors in the RON-KO
background suggesting that lack of RON in the innate immune
compartment facilitates generation of a CTL response against
the tumor (34). These observations support the hypothesis that
ablation of RON function in the innate immune compartment
accentuates tumor-specific T-cell responses.
In the last few years, tumor-associated macrophages have
received significant attention due to their pro-tumorigenic prop-
erties, such as producing tumor-promoting and pro-angiogenic
factors and suppression of the adaptive immune response within
the tumor microenvironment (43). Polarization of macrophages
into an M2-type is one of the mechanisms that subverts the
sentinel function of the innate immune cells and make them
pro-tumorigenic.
How can this immune-modulatory property of RON be recon-
ciled with normal tissue homeostasis? Maintaining macrophages
in M1/M2-like polarized state is important under certain physio-
logical conditions. For example, during wound healing or during
repair of damaged tissues, macrophages serve two important func-
tions. First, it is ready to mount an immune response to eliminate
pathogens, if the wound site gets infected, and during the same
time limit the intensity and duration of the localized immune
response to prevent further tissue damage. Second, it needs to
produce growth-promoting and tissue-rebuilding factors to accel-
erate healing and reverse damage. In this context, the tissue repair
or wound healing pathways of macrophages are co-opted by the
tumor to promote its own survival against immune attack and
activation of RON in the tumor microenvironment may facilitate
this conversion.
CONCLUSION AND THERAPEUTIC IMPLICATIONS
M1 and M2 polarization of macrophages is dynamically con-
trolled by changes in the tissue microenvironment. These two
functional states participate in two important activities – protec-
tion against foreign pathogens and promotion of tissue restoration
and healing after injury. Therefore, tight regulation of these two
states is critical to the health of the organism (Figure 1B). Sus-
tained activation of M1 state can lead to excessive tissue damage
as a result of excessive inflammation, whereas prolonged acti-
vation of the M2 state can cause chronic inflammation leading
to cancer. Therapeutic targeting of certain diseases may involve
artificial manipulation of macrophage polarization. As an exam-
ple, inhibiting RON function in tumor-associated macrophages
can restore tumor immunity allowing enhanced efficacy of can-
cer immunotherapy drugs. Similarly, enhancing RON activity in
tissue-associated macrophages can lead to efficient wound healing
and restoration of tissue damage. However, such artificial manip-
ulation of immune cell functions has to be tightly controlled to
prevent systemic damage to the organism.
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